Latest
Washington Research Foundation Welcomes Dr. Orin Levine as New President to Navigate Funding Challenges and Propel Life Sciences Innovations
Residex Acquires Kevala: A Game-Changer for Senior Care Technology Through AI and Workforce Optimization
Funko Appoints Former Netflix Executive Josh Simon as CEO Amid Financial Challenges
DarioHealth Q2 Results May Present Compelling Long-Term Story Despite Near-Term Revenue Headwinds
Meet Entera Bio: The $85M Company That Could Solve Big Pharma’s Oral GLP-1 Problem
Microsoft’s GPT-5 Rollout Sparks Competitive Exchange with Elon Musk Amid Shifting AI Partnerships
Zillow’s Strong Q2 Performance Highlights Resilience and Strategic Growth Amidst Housing Market Challenges
Upstack Acquires Avail Partners to Bolster Cloud and Cybersecurity Consulting Services in Strategic Expansion
Fable’s Showrunner: Revolutionizing TV with AI-Powered User-Generated Content
Laidlaw Analyst Doubles Down on Nuvectis Citing NXP900 as True Value Driver; Reiterates $19 Price Target
Revolutionizing Agriculture: 4AG Robotics Secures $29 Million to Transform Mushroom Harvesting with Cutting-Edge Automation
Lithium Market’s Razor-Thin Balance Exposed: Why NOA Lithium Brines Inc. (TSXV: NOAL) Benefits from Supply Chain Fragility
Seattle-Tacoma International Airport Launches Groundbreaking Autonomous Shuttle Program to Enhance Passenger Mobility
NXP900: The Breakthrough Drug That Could Transform Nuvectis Pharma Into a Multi-Billion Dollar Biotech Giant
Revolutionizing AI: ACME Brains’ nexie Redefines User Privacy and Personal Context
The $100 Billion Bet: Why Palatin Technologies Could Be 2025’s Most Overlooked Biotech Opportunity
Leadership Shifts Fuel Innovation in Pacific Northwest Tech Sector
BiomX Advances with Phase 2b Trial Initiation, Wall Street Analyst Reaffirms $15 Price Target
Quandri Secures $12 Million to Revolutionize Insurance with AI-Powered Automation
Roth Capital Analyst Reiterates $9 Price Target for PolyPid Following GLP-1 News
